Product Overview
Thymalin: Immunoregulatory Peptide Complex
Thymalin is a thymic peptide complex with established immunoregulatory, anti-aging, and cellular rejuvenation actions. Core activity includes stimulation of T-cell differentiation/maturation and modulation of cytokine and inflammatory pathways; it has been used clinically as an immunomodulator in several countries.[1,2]
Immune Regulatory Effects
- Promotes T-cell differentiation, maturation, proliferation, and cytokine production, strengthening adaptive immunity in immunosenescence, thymic hypoplasia, recurrent infections, and oncology settings.[1,2]
- In vitro, Thymalin/thymic peptides modulate monocyte/macrophage proliferation and inflammation, reducing TNF and IL-6 and decreasing adhesion to activated endothelium.[3]
Anti-Aging & Geroprotective Outcomes
- Long-term studies in elderly cohorts report normalization of cardiovascular, endocrine, immune, and nervous system function with fewer ARIs, IHD, hypertension, osteoarthritis, and osteoporosis events.[4]
- Observed mortality reduction up to 2.0–2.1× vs controls with Thymalin alone and up to 4.1× when combined with pineal peptides.[4]
- Geroprotective actions attributed to restoration of thymic output and reversal of immunosenescence.[2,4]
Cellular Rejuvenation & Inflammatory Modulation
- Regulates MAPK-linked tyrosine phosphorylation and suppresses pro-inflammatory cytokines in innate immune cells; attenuates NF-κB/MAPK/PKC-θ signaling and reduces lymphocyte apoptosis in chronic inflammation models.[3,7]
- Related thymic peptides (e.g., thymulin) show anti-inflammatory/analgesic CNS and peripheral effects; gene therapy restoration of thymic peptides prevents neuroendocrine/metabolic abnormalities in deficiency states.[5–7]
Clinical Applications & Safety
- Used as an adjunct immunomodulator for immunodeficiency, autoimmune disease, infections, and supportive oncology; also applied to mitigate immunosenescence and enhance healthspan in aging populations.[1,2,4]
- Extensive preclinical and clinical experience reports favorable tolerability without significant long-term adverse effects.[1,4]
Key Takeaways
- Restores immune competence via T-cell maturation and cytokine balance.
- Geroprotective signal with reported multi-system normalization and reduced mortality in elderly cohorts.
- Inflammation control through NF-κB/MAPK pathway modulation and apoptosis regulation.
References
- Rodriguez Martin RR, et al. Int Immunopharmacol. 2023;119:110167. doi:10.1016/j.intimp.2023.110167.[1]
- Khavinson VKh. Neuro Endocrinol Lett. 2002;23(Suppl 3):11-144.[2]
- Avolio F, et al. Int J Mol Sci. 2022;23(7):3607. doi:10.3390/ijms23073607.[3]
- Khavinson VKh, Morozov VG. Neuro Endocrinol Lett. 2003;24(3-4):233-240.[4]
- Reggiani PC, et al. Curr Pharm Des. 2014;20(29):4690-4696.[5]
- Reggiani PC, et al. Ann NY Acad Sci. 2009;1153:98-106.[6]
- Novoselova EG, et al. PLoS One. 2018;13(5):e0197601. doi:10.1371/journal.pone.0197601.[7]
All information provided is for research purposes only.
All COA’s available upon request: info@truformlabs.com
All information provided is for research purposes only.
Storage & Handling (Research Use)
- Lyophilized powder: Store sealed at −20 °C to −80 °C (desiccated, light-protected). Short-term (≤2–3 weeks) at 2–8 °C acceptable.
- After reconstitution: Store at 2–8 °C and use within 7 days, or aliquot and freeze at −20 °C to −80 °C for ≤3 months.
- Handling: Prepare small aliquots to avoid freeze–thaw; keep on ice during prep; minimize air/light exposure.
- Vehicle & pH: Reconstitute per lot guidance (e.g., sterile saline/BWFI) near pH 7.0–7.4; avoid reactive metals/oxidants.
- Labeling: Record concentration, solvent, and prep date; follow lab SOPs and lot-specific stability notes.
All information provided is for research purposes only.